Heart Transplantation — CPB 0586 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0586 governing heart transplantation coverage, effective September 26, 2025. If your team bills CPT 33945 for heart transplant or CPT 33927–33929 for total artificial heart procedures, review the updated selection criteria now.

Aetna's heart transplantation coverage policy under CPB 0586 covers one of the highest-cost episodes in cardiovascular medicine. A single claim denial on a transplant case can mean six-figure write-offs and months of appeals. This update touches medical necessity criteria, absolute contraindications, HIV-positive recipient eligibility, rejection monitoring codes (CPT 81595, 0055U, 0087U, 0493U, 0540U), and the AI-assisted diagnostics category — making it one of the more substantive revisions to this policy in recent years.

Quick-Reference Table

Aetna Heart Transplantation Coverage Criteria and Medical Necessity Requirements 2025

Aetna considers heart transplantation medically necessary when a member meets the transplanting institution's protocol eligibility criteria. That's the threshold sentence — and it has real billing weight. If your institution has a formal transplant protocol on file with Aetna, members meeting that protocol qualify without needing to satisfy every individual criterion below. Document the protocol reference in every prior authorization submission.

When no protocol exists, all of the following selection criteria must be met. NYHA Class III or IV heart failure is required — but Aetna explicitly exempts pediatric members from this requirement. That's a meaningful carve-out your team should flag in your CDM workflow for pediatric transplant cases.

The full off-protocol selection criteria are:

The HIV eligibility criteria deserve close attention. Aetna covers transplantation for HIV-positive members — but the specifics are tight. All four HIV sub-criteria must be met simultaneously. If a member's viral load is detectable at the time of prior authorization, the request will fail. Document lab values with dates in every auth packet.

Covered indications under this coverage policy include cardiac arrhythmia, graft failure requiring re-transplantation, cardiomyopathy (nutritional, metabolic, hypertrophic, or restrictive), congenital heart disease, end-stage ventricular failure, idiopathic dilated cardiomyopathy, inability to wean from temporary cardiac-assist devices post-MI or post-surgery, intractable coronary artery disease, myocarditis, post-partum cardiomyopathy, right ventricular dysplasia/cardiomyopathy, and valvular heart disease.

Prior authorization requirements for CPT 33945 and 33927–33929 on Aetna lives should be confirmed with the member's plan directly. CPB 0586 establishes medical necessity criteria; authorization workflow requirements are plan-specific and are not enumerated in this policy bulletin.

Aetna Heart Transplantation Exclusions and Non-Covered Indications

Aetna maintains a list of absolute contraindications that disqualify a member from coverage regardless of other criteria. These are not soft relative contraindications — they are hard stops. The full list of absolute contraindications is defined in CPB 0586. Because absolute contraindications are hard stops for coverage, review the complete policy at the source before submitting prior authorization.

The policy also addresses what Aetna considers experimental or investigational. Certain AI-assisted and genomic monitoring tools fall into a distinct category within CPB 0586. CPT codes 0055U, 0087U, 0493U, 0540U, 71275, and 84484 are grouped under "use of machine learning and artificial intelligence in cardiology" — a category label that signals Aetna is tracking but not yet broadly covering these tools under standard medical necessity. Reimbursement for these codes will depend on plan-level benefit language and may require separate coverage review.

If your institution uses donor-derived cell-free DNA assays (CPT 0493U or 0540U) for rejection surveillance, don't assume coverage on Aetna lives. Verify plan-specific benefit coverage before the test is ordered, not after the claim drops.

Coverage Indications at a Glance

Aetna Heart Transplantation Billing Guidelines and Action Items 2025

1. Update your prior auth templates before September 26, 2025.
Every auth packet for CPT 33945 or 33927–33929 on Aetna lives needs to reflect the current CPB 0586 selection criteria. Include documentation for every line item — NYHA class, life expectancy assessment, organ function labs, infection status, HIV status with lab dates, and psychiatric/substance use evaluation. Missing one criterion is enough for Aetna to deny.

2. Flag pediatric cases separately in your workflow.
The NYHA Class III/IV requirement does not apply to pediatric members. Build that exception into your auth checklist so your team doesn't incorrectly screen out pediatric candidates based on functional classification alone.

3. Verify HIV-positive member eligibility with current lab values.
All four HIV sub-criteria must be documented at the time of prior authorization. Pull the CD4 count, HIV-1 RNA viral load, antiviral therapy start date, and AIDS complication history. Do this before submitting — not in response to a denial.

4. Separate your AI/ML monitoring code strategy.
CPT 0055U, 0087U, 0493U, and 0540U sit in a distinct category under CPB 0586. Don't assume these bill the same way as CPT 81595 (the 20-gene expression panel, which is covered when selection criteria are met). For donor-derived cell-free DNA assays, check the member's plan benefits before the test is ordered. A claim denial on a $3,000+ molecular test is avoidable.

5. Confirm cardiac rehabilitation reimbursement at the plan level.
CPT 93798, HCPCS G0422, and HCPCS S9472 are listed as related codes under this CPB. Post-transplant cardiac rehab reimbursement varies by plan. Verify coverage and session limits before the patient starts the program, especially for S9472 (non-physician provider, per diem).

6. Document transplanting institution protocol status on every claim.
If your center has a formal transplant protocol accepted by Aetna, reference it explicitly in your prior auth and clinical documentation. Protocol-eligible members do not need to meet every off-protocol selection criterion. This distinction can be the difference between approval and denial on complex cases.

7. Audit any open claims for troponin (CPT 84484) and chest CTA (CPT 71275).
These codes appear in the AI/ML category under CPB 0586. If your team has been billing them as standard cardiac workup on transplant cases, verify the claim basis. The grouping in this category may trigger additional scrutiny.

CPT, HCPCS, and ICD-10 Codes for Heart Transplantation Under CPB 0586

Covered CPT Codes (When Selection Criteria Are Met)

Covered HCPCS Codes (When Selection Criteria Are Met)

Other CPT Codes Related to CPB 0586

Other HCPCS Codes Related to CPB 0586

AI/ML and Investigational Category — Verify Plan Coverage Before Billing

Key ICD-10-CM Diagnosis Codes Supported by CPB 0586

Note: The full ICD-10 code set under CPB 0586 includes 160 codes. The table above reflects the primary diagnostic categories. Review the full policy at app.payerpolicy.org/p/aetna/0586. for the complete list.